Bendacort is an ester of glucocorticosteroid hydrocortisone and non-steroidal anti-inflammatory drug bendazac. In vivo studies demonstrated that bendacort has a wider spectrum of anti-inflammatory effects than bendazac or hydrocortisone alone: bendacort acts on responses with a necrotic evolution where tissue damage predominates, and in cases where the reaction of tissue defense predominates, as for example in the healing of wounds. Bendacort was marketed in Italy under tradename Versacort for the treatment of sensitive steroid dermatoses, contact eczema, dyshidrosis, insect bites.